{"filing":{"accession_number":"0001437749-26-020005","cik":"0001710340","ticker":"ETON","company_name":"Eton Pharmaceuticals, Inc.","form":"8-K","filing_date":"2026-06-09","report_date":null,"primary_document":"eton20260409_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1710340/000143774926020005/eton20260409_8k.htm"},"events":[{"id":6002,"run_id":5267,"accession_number":"0001437749-26-020005","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"This is a clear disclosure of shareholder vote results from the 2026 Annual Meeting of Stockholders held on June 9, 2026. The filing reports voting outcomes for two proposals: (1) election of directors Jenn Adams and Charles J. Casamento, and (2) ratification of Grant Thornton LLP as independent auditor. The detailed vote tallies (For, Against, Withheld, Abstain, Broker Non-Votes) are presented in tabular form, which is the standard format for Item 5.07 disclosures of shareholder meeting results.","company_name":"Eton Pharmaceuticals, Inc.","ticker":"ETON","filing_date":"2026-06-09","form":"8-K","submitted_at":null,"items":[{"id":5585,"accession_number":"0001437749-26-020005","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder vote results from the 2026 Annual Meeting of Stockholders held on June 9, 2026. The filing reports voting outcomes for two proposals: (1) election of directors Jenn Adams and Charles J. Casamento, and (2) ratification of Grant Thornton LLP as independent auditor. The detailed vote tallies (For, Against, Withheld, Abstain, Broker Non-Votes) are presented in tabular form, which is the standard format for Item 5.07 disclosures of shareholder meeting results.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-09T20:33:34.862272+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":5585,"accession_number":"0001437749-26-020005","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder vote results from the 2026 Annual Meeting of Stockholders held on June 9, 2026. The filing reports voting outcomes for two proposals: (1) election of directors Jenn Adams and Charles J. Casamento, and (2) ratification of Grant Thornton LLP as independent auditor. The detailed vote tallies (For, Against, Withheld, Abstain, Broker Non-Votes) are presented in tabular form, which is the standard format for Item 5.07 disclosures of shareholder meeting results.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-09T20:33:34.862272+00:00","company_name":"Eton Pharmaceuticals, Inc.","ticker":"ETON","filing_date":"2026-06-09"}]}